Skip to content

Clinical trials

Phase 2 Huntington Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Phase: Phase 2 Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20054
20072
20081
20092
20102
20115
20122
20132
20145
20154
20161
20171
20183
20191
20202
20211
20224
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated7
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital4
Novartis Pharmaceuticals4
Pfizer3
Prilenia3
Charite University, Berlin, Germany2
Hoffmann-La Roche2
Institut National de la Santé Et de la Recherche Médicale, France2
National Institute of Neurological Disorders and Stroke (NINDS)2
SOM Innovation Biotech SA2
Supernus Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease51
Chorea9
Attention Deficit Disorder with Hyperactivity2
Neurodegenerative Diseases2
Rare Diseases2
Dyskinesias1
Lethargy1
Prodromal Symptoms1

Trials

Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.